310 related articles for article (PubMed ID: 36416821)
1. Association of Opioid and Stimulant Use Disorder Diagnoses With Fatal and Nonfatal Overdose Among People With a History of Incarceration.
Palis H; Gan W; Xavier C; Desai R; Scow M; Sedgemore KO; Greiner L; Nicholls T; Slaunwhite A
JAMA Netw Open; 2022 Nov; 5(11):e2243653. PubMed ID: 36416821
[TBL] [Abstract][Full Text] [Related]
2. Concurrent use of opioids and stimulants and risk of fatal overdose: A cohort study.
Palis H; Xavier C; Dobrer S; Desai R; Sedgemore KO; Scow M; Lock K; Gan W; Slaunwhite A
BMC Public Health; 2022 Nov; 22(1):2084. PubMed ID: 36380298
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of co-occurring mental illness and substance use disorder and association with overdose: a linked data cohort study among residents of British Columbia, Canada.
Keen C; Kinner SA; Young JT; Jang K; Gan W; Samji H; Zhao B; Krausz M; Slaunwhite A
Addiction; 2022 Jan; 117(1):129-140. PubMed ID: 34033179
[TBL] [Abstract][Full Text] [Related]
4. Stimulant use disorder diagnosis and opioid agonist treatment dispensation following release from prison: a cohort study.
Palis H; Zhao B; Young P; Korchinski M; Greiner L; Nicholls T; Slaunwhite A
Subst Abuse Treat Prev Policy; 2022 Nov; 17(1):77. PubMed ID: 36434706
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
[TBL] [Abstract][Full Text] [Related]
6. Use of community healthcare and overdose in the 30 days following release from provincial correctional facilities in British Columbia.
McLeod KE; Karim ME; Buxton JA; Martin RE; Scow M; Felicella G; Slaunwhite AK
Drug Alcohol Depend; 2021 Dec; 229(Pt A):109113. PubMed ID: 34823082
[TBL] [Abstract][Full Text] [Related]
7. Association of Methamphetamine and Opioid Use With Nonfatal Overdose in Rural Communities.
Korthuis PT; Cook RR; Foot CA; Leichtling G; Tsui JI; Stopka TJ; Leahy J; Jenkins WD; Baker R; Chan B; Crane HM; Cooper HL; Feinberg J; Zule WA; Go VF; Estadt AT; Nance RM; Smith GS; Westergaard RP; Van Ham B; Brown R; Young AM
JAMA Netw Open; 2022 Aug; 5(8):e2226544. PubMed ID: 35969400
[TBL] [Abstract][Full Text] [Related]
8. Risk of overdose-related death for people with a history of incarceration.
Gan WQ; Kinner SA; Nicholls TL; Xavier CG; Urbanoski K; Greiner L; Buxton JA; Martin RE; McLeod KE; Samji H; Nolan S; Meilleur L; Desai R; Sabeti S; Slaunwhite AK
Addiction; 2021 Jun; 116(6):1460-1471. PubMed ID: 33047844
[TBL] [Abstract][Full Text] [Related]
9. Signals of increasing co-use of stimulants and opioids from online drug forum data.
Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA
Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501
[TBL] [Abstract][Full Text] [Related]
10. Association of Opioid Dose Reduction With Opioid Overdose and Opioid Use Disorder Among Patients Receiving High-Dose, Long-term Opioid Therapy in North Carolina.
DiPrete BL; Ranapurwala SI; Maierhofer CN; Fulcher N; Chelminski PR; Ringwalt CL; Ives TJ; Dasgupta N; Go VF; Pence BW
JAMA Netw Open; 2022 Apr; 5(4):e229191. PubMed ID: 35476064
[TBL] [Abstract][Full Text] [Related]
11. Effect of Risk Mitigation Guidance opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study.
Slaunwhite A; Min JE; Palis H; Urbanoski K; Pauly B; Barker B; Crabtree A; Bach P; Krebs E; Dale L; Meilleur L; Nosyk B
BMJ; 2024 Jan; 384():e076336. PubMed ID: 38199614
[TBL] [Abstract][Full Text] [Related]
12. Predictive Modeling of Opioid Overdose Using Linked Statewide Medical and Criminal Justice Data.
Saloner B; Chang HY; Krawczyk N; Ferris L; Eisenberg M; Richards T; Lemke K; Schneider KE; Baier M; Weiner JP
JAMA Psychiatry; 2020 Nov; 77(11):1155-1162. PubMed ID: 32579159
[TBL] [Abstract][Full Text] [Related]
13. Patient characteristics and treatment utilization in fatal stimulant-involved overdoses in the United States Veterans Health Administration.
Coughlin LN; Zhang L; Bohnert ASB; Maust DT; Goldstick J; Lin LA
Addiction; 2022 Apr; 117(4):998-1008. PubMed ID: 34648209
[TBL] [Abstract][Full Text] [Related]
14. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
[TBL] [Abstract][Full Text] [Related]
15. Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose.
Abouk R; Pacula RL; Powell D
JAMA Intern Med; 2019 Jun; 179(6):805-811. PubMed ID: 31058922
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of fatal opioid overdoses with stimulant involvement in Tennessee: A descriptive study using 2018 State Unintentional Drug Overdose Reporting System Data.
Korona-Bailey JA; Nechuta S; Golladay M; Moses J; Bastasch O; Krishnaswami S
Ann Epidemiol; 2021 Jun; 58():149-155. PubMed ID: 33744415
[TBL] [Abstract][Full Text] [Related]
17. The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States.
Hoots B; Vivolo-Kantor A; Seth P
Addiction; 2020 May; 115(5):946-958. PubMed ID: 31912625
[TBL] [Abstract][Full Text] [Related]
18. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
[TBL] [Abstract][Full Text] [Related]
19. Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose.
Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM
JAMA Intern Med; 2024 Jun; ():. PubMed ID: 38884975
[TBL] [Abstract][Full Text] [Related]
20. Characterizing stimulant overdose: A qualitative study on perceptions and experiences of "overamping".
Mansoor M; McNeil R; Fleming T; Barker A; Vakharia S; Sue K; Ivsins A
Int J Drug Policy; 2022 Apr; 102():103592. PubMed ID: 35114520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
